TLR4 and Insulin Resistance.
Chronic inflammation is a key feature of insulin resistance and obesity. Toll-Like Receptor 4 (TLR4), involved in modulating innate immunity, is an important mediator of insulin resistance and its comorbidities. TLR4 contributes to the development of insulin resistance and inflammation through its activation by elevated exogenous ligands (e.g., dietary fatty acids and enteric lipopolysaccharide) and endogenous ligands (e.g., free fatty acids) which are elevated in obese states. TLR4, expressed in insulin target tissues, activates proinflammatory kinases JNK, IKK, and p38 that impair insulin signal transduction directly through inhibitory phosphorylation of insulin receptor substrate (IRS) on serine residues. TLR4 activation also leads to increased transcription of pro-inflammatory genes, resulting in elevation of cytokine, chemokine, reactive oxygen species, and eicosanoid levels that promote further insulin-desensitization within the target cell itself and in other cells via paracrine and systemic effects. Increased understanding of cell type-specific TLR4-mediated effects on insulin action present the opportunity and challenge of developing related therapeutic approaches for improving insulin sensitivity while preserving innate immunity.
Kim
Jane J
JJ
Department of Pediatrics, University of California, San Diego, CA 92093-0673, USA.
Sears
Dorothy D
DD
Circ Res. 2007 Jun 8;100(11):1589-96
17478729
Gastroenterol Res Pract. 2010;2010:362847
21274430
Diabetologia. 2009 Feb;52(2):318-28
19052722
Intensive Care Med. 2000;26 Suppl 1:S51-6
10786959
Immunity. 2007 Aug;27(2):321-33
17707128
Obesity (Silver Spring). 2008 Jun;16(6):1248-55
18421279
FEMS Immunol Med Microbiol. 2009 Aug;56(3):241-7
19552715
J Biol Chem. 2000 Aug 11;275(32):24255-63
10823826
J Diabetes Complications. 2010 May-Jun;24(3):192-8
19395279
Science. 1996 Feb 2;271(5249):665-8
8571133
J Lipid Res. 2005 Sep;46(9):1904-13
15930520
J Biol Chem. 2001 Oct 5;276(40):37335-40
11489905
Diabetes. 2008 Jun;57(6):1470-81
18305141
Mol Cells. 2006 Apr 30;21(2):174-85
16682810
Endocrinology. 2009 Dec;150(12):5218-29
19819943
J Immunol. 2004 Mar 1;172(5):3173-80
14978124
FASEB J. 2007 Sep;21(11):2840-8
17475921
Cell Metab. 2009 Feb;9(2):125-39
19187771
J Lipid Res. 2009 Jan;50(1):90-7
18815435
Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):979-84
17210919
Immunol Today. 1997 Oct;18(10):478-82
9357139
Endocrinology. 2009 Aug;150(8):3457-64
19389833
J Clin Invest. 1980 Jun;65(6):1272-84
6997333
Am J Physiol Gastrointest Liver Physiol. 2007 Feb;292(2):G518-25
17023554
Diabetes. 2008 Oct;57(10):2595-602
18633101
Cell Metab. 2005 Jan;1(1):63-72
16054045
FEBS Lett. 2005 Dec 19;579(30):6821-6
16325814
J Leukoc Biol. 1996 Mar;59(3):442-50
8604025
FEBS Lett. 2008 Jan 9;582(1):97-105
18053812
Endocrinology. 2009 Aug;150(8):3877-84
19406943
Ann N Y Acad Sci. 2008 Dec;1150:146-8
19120284
J Clin Invest. 2008 Sep;118(9):2992-3002
18769626
Immunology. 2008 Nov;125(3):344-58
18422969
Diabetes Care. 2010 Apr;33(4):861-8
20067962
Diabetes. 2007 Aug;56(8):1986-98
17519423
Diabetes. 2002 Jun;51(6):1907-12
12031980
Nature. 2009 Apr 30;458(7242):1191-5
19252480
J Leukoc Biol. 2009 Sep;86(3):557-66
19451397
J Lipid Res. 2005 Nov;46(11):2347-55
16150820
Nat Rev Immunol. 2008 Dec;8(12):923-34
19029988
J Clin Invest. 2006 Nov;116(11):3015-25
17053832
Am J Clin Nutr. 2007 Nov;86(5):1286-92
17991637
J Biol Chem. 2006 Sep 15;281(37):26865-75
16798732
Cell Metab. 2008 Oct;8(4):301-9
18840360
Nature. 2008 Oct 23;455(7216):1109-13
18806780
Biochim Biophys Acta. 2008 Feb;1778(2):466-71
18068112
J Clin Invest. 2003 Dec;112(12):1821-30
14679177
Circulation. 2008 Sep 30;118(14):1467-75
18794388
Arch Physiol Biochem. 2009 Oct;115(4):176-90
19671019
Diabetologia. 2007 Jun;50(6):1267-76
17426960
J Immunol. 2008 Dec 15;181(12):8633-41
19050283
J Biol Chem. 2003 Jun 20;278(25):22523-9
12686536
Endocrinology. 2005 Oct;146(10):4192-9
16002529
Nat Rev Drug Discov. 2009 May;8(5):386-98
19404312
Infect Immun. 2006 Dec;74(12):6829-38
16982839
Curr Opin Lipidol. 2009 Oct;20(5):379-85
19625959
Circ Res. 2007 Jun 8;100(11):1531-3
17556663
Cell. 2009 Sep 4;138(5):961-75
19737522
Cell Metab. 2007 Nov;6(5):386-97
17983584
Arterioscler Thromb Vasc Biol. 2005 Jun;25(6):1225-30
15802626
Hepatology. 2009 Aug;50(2):592-600
19492426
Arterioscler Thromb Vasc Biol. 2009 Nov;29(11):1944-9
19661481
Annu Rev Physiol. 2010;72:219-46
20148674
Am J Physiol Endocrinol Metab. 2007 Mar;292(3):E740-7
17090751
Histochem Cell Biol. 2007 Feb;127(2):131-7
16988837
Arterioscler Thromb Vasc Biol. 2010 Jan;30(1):24-30
19834103
Biol Reprod. 2008 Mar;78(3):432-7
18003947
Diabetes. 2005 Nov;54(11):3182-9
16249443
Am J Physiol Endocrinol Metab. 2010 May;298(5):E988-98
20179247
J Biol Chem. 2001 May 18;276(20):16683-9
11278967
Mol Med. 2008 May-Jun;14(5-6):346-52
18231573
J Leukoc Biol. 2009 Sep;86(3):573-6
19414536
Science. 2001 Aug 31;293(5535):1673-7
11533494
Trends Cardiovasc Med. 2009 Oct;19(7):227-32
20382346
Nutr Metab Cardiovasc Dis. 2009 Dec;19(10):736-43
19356913
Obesity (Silver Spring). 2009 May;17(5):973-9
19165171
J Leukoc Biol. 2006 Apr;79(4):803-8
16434692
J Clin Invest. 2004 Sep;114(6):823-7
15372106
J Nutr. 2009 Dec;139(12):2351-7
19846417
Circulation. 2004 Jan 27;109(3):433-8
14744958
Life Sci. 2008 Sep 26;83(13-14):502-10
18761356
Nat Med. 2004 Apr;10(4):416-21
15034566
PLoS One. 2009;4(4):e5045
19340313
Immunol Res. 2006;34(3):177-92
16891670
Arterioscler Thromb Vasc Biol. 2009 Mar;29(3):341-7
19095997
J Clin Invest. 1985 Jul;76(1):149-55
3894418
Infect Immun. 2003 Aug;71(8):4414-20
12874320
Diabetes. 2007 Jul;56(7):1761-72
17456850
Annu Rev Biochem. 1990;59:129-70
1695830
Curr Pharm Des. 2009;15(13):1546-58
19442172
J Lipid Res. 2003 Mar;44(3):479-86
12562875
Science. 1987 Aug 21;237(4817):885-8
3303333
J Immunol. 2006 Mar 1;176(5):3070-9
16493066
Biochem Biophys Res Commun. 2006 Aug 4;346(3):739-45
16781673
Nat Rev Immunol. 2006 Jan;6(1):44-55
16493426
Diabetologia. 2008 Nov;51(11):2060-7
18758745
Hepatology. 1986 Jul-Aug;6(4):718-22
3733004
J Biol Chem. 2007 Nov 30;282(48):35279-92
17916553
Am J Physiol. 1988 Dec;255(6 Pt 1):E769-74
3059816
Cell Metab. 2009 Oct;10(4):249-59
19808018
J Hepatol. 2009 Jul;51(1):212-23
19447517
J Gastroenterol Hepatol. 2008 Mar;23 Suppl 1:S50-3
18336664
Biochem Biophys Res Commun. 2007 Mar 2;354(1):45-9
17210129
Diabetes. 2001 Jun;50(6):1344-50
11375335
Metabolism. 2010 May;59(5):711-7
19922963
Biochem Soc Trans. 2000 Feb;28(2):212-5
10816130
Nat Med. 2005 Feb;11(2):191-8
15685170
FASEB J. 2008 Jul;22(7):2416-26
18326786
J Biol Chem. 2009 Oct 2;284(40):27384-92
19648648
Mol Cell Endocrinol. 2010 Mar 25;316(2):129-39
19723556
Science. 1998 Dec 11;282(5396):2085-8
9851930
Immunology. 2008 Sep;125(1):59-69
18373668
Hepatology. 2010 Apr;51(4):1420-9
20052772
Cell Metab. 2009 Nov;10(5):419-29
19883619
J Immunol. 1999 Apr 1;162(7):3749-52
10201887
J Clin Invest. 2003 Dec;112(12):1796-808
14679176
J Leukoc Biol. 2007 Sep;82(3):657-65
17575266
Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10679-84
15249654
Hepatology. 2009 Oct;50(4):1094-104
19637282
Obesity (Silver Spring). 2008 May;16(5):932-7
18292749
Am J Physiol Regul Integr Comp Physiol. 2008 Mar;294(3):R673-80
18094066
Immunol Today. 1993 Jul;14(7):353-6
8363725
Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):84-91
17082484